Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (34)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Özgür, O.
Right arrow Articles by Haberal, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Özgür, O.
Right arrow Articles by Haberal, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (1995) 10: 2104-2106
© 1995 European Renal Association-European Dialysis and Transplant Association

research-article

Recombinant {alpha}-interferon in renal allograft recipients with chronic hepatitis C

O. Özgür, S. Boyacioglu, H. Telatar and M. Haberal

Baskent University Hospital Turkey

Correspondence and offprint requests to: Correspondence and offprint requests to: Prof. Dr Mehmet Haberal, 1. Cadde No: 77 Kat: 4, 06490, Bachçelievler, Ankara, Türkiye

BACKGROUND.: Although chronic hepatitis C infection is one of the factors that can lead to morbidity and mortality in renal allograft recipients, treatment procedures have not been well documented. Interferon treatment has been shown to be effective in the normalization of biochemical hepatitis C and in the clearing of hepatitis C virus RNA. However, little is known concerning the efficacy and safety of interferon treatment in renal allograft recipients with chronic hepatitis C. Interferon has also been accused of increasing renal allograft rejection.

METHODS.: Recombinant {alpha}-interferon in a dose of 4.5 million units three times per week was given to five renal-allograft recipients with chronic hepatitis C for 6 months. Besides biochemical investigations, liver histopathologies before and after the treatment course were also studied.

RESULTS.: Interferon treatment was effective in two of the patients, in another two cases renal function deteriorated during the treatment. In the last case ALT increased again after cessation of interferon therapy.

CONCLUSION.: We conclude that interferon seems to be moderately effective in treating chronic hepatitis C in renal allograft recipients, but a risk of renal functional deterioration and rejection remains.

Keywords: hepatitis C virus infection; interferon; renal allograft recipients


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CJASNHome page
N. A. Terrault and D. B. Adey
The Kidney Transplant Recipient with Hepatitis C Infection: Pre- and Posttransplantation Treatment
Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 563 - 575.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
B. L. KASISKE, M. A. VAZQUEZ, W. E. HARMON, R. S. BROWN, G. M. DANOVITCH, R. S. GASTON, D. ROTH, J. D. SCANDLING JR., and G. G. SINGER
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
J. Am. Soc. Nephrol., October 1, 2000; 11 (90001): S1 - S86.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. M. MORALES and J. M. CAMPISTOL
Transplantation in the Patient with Hepatitis C
J. Am. Soc. Nephrol., July 1, 2000; 11(7): 1343 - 1353.
[Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.